Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD based on severity of airflow limitation.
Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD (SGRQ-C) based on severity of airflow limitation.
The study, published in the International Journal of COPD, included 1264 patients who were categorized into 2 groups based on the severity of airflow limitation: mild-to-moderate COPD and severe-to-very severe COPD.
“The substantial symptomatic burden of COPD reduces physical and psychological functioning, ultimately decreasing health-related quality of life (HRQoL),” explained the authors.
They sought to analyze the SGRQ-C, which is used to grade symptoms, to identify factors associated with a high score in patients with stable COPD based on the severity of airflow limitation.
The study selected patients in the Korean COPD Subgroup Study cohort and recorded a variety of data, including age, sex, height, weight, smoking status, comorbidities, 6-minute walk distance, cough, sputum, and SGRQ-C score. Of the 902 patients who had mild-to-moderate COPD, 534 (59.2%) had a high SGRQ-C score, and of the 362 patients with severe-to-very severe COPD, 261 (80.4%) had a high SGRQ-C score.
Compared with patients with a low SGRQ-C score, patients with mild-to-moderate COPD and a high score were more likely to be less educated, have more comorbidities, and suffer from more respiratory symptoms, such as cough, sputum, and dyspnea. These patients also had a “significantly lower level” of exercise capacity as determined by the 6-minute walk distance.
Patients with severe-to-very severe COPD and a high score were more likely to have a lower body mass index, a history of pneumonia, osteoporosis, and respiratory symptoms, such as cough, sputum, and dyspnea. Similar to patients with mild-to-moderate COPD, this group had a significantly shorter 6-minute walk distances compared with similar patients with a low SGRQ-C score. No comorbidities were associated with a high score for this group.
Overall, the researchers found a negative correlation between HRQoL and severity of airflow limitation. The fact that only respiratory symptoms were significantly associated with a high SGRQ-C score “indicates the need for an improved management strategy for relieving respiratory symptoms in COPD patients with poor HRQoL,” the authors concluded.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
2 Commerce Drive
Cranbury, NJ 08512